JNJ vs PFE: Stock Comparison

Johnson & Johnson (JNJ) and Pfizer, Inc. (PFE) compared side by side on 20 fundamental metrics — valuation, profitability, growth, balance sheet, and returns. Live data, updated hourly.

JNJ trades at the lower earnings multiple (31.35x vs 37.88x), while JNJ has the higher return on equity (25.74% vs 4.89%).

Metric JNJ PFE
Stock Price $263.81 $30.03
Market Cap $635.1B $171.2B
P/E Ratio 31.35 37.88
P/B Ratio 7.79 1.92
P/S Ratio 6.67 2.57
EV/EBITDA 20.22 17.87
PEG Ratio -3.88 -0.63
Return on Equity 25.74% 4.89%
ROCE 17.96% 9.48%
Return on Assets 10.46% 2.16%
Gross Margin 67.91% 71.32%
Net Margin 21.48% 6.81%
Revenue Growth (1y) +6.05% -1.65%
Profit Growth (1y) +90.56% -3.12%
Debt / Equity 0.58 0.74
Current Ratio 1.09 1.27
Interest Coverage 25.94 5.92
Dividend Yield 1.98% 6.00%
Beta 0.24 0.3
1-Year Return +40.15% +30.26%

Green bold marks the higher value on each metric, or the lower value for valuation multiples and debt-to-equity. It shows direction only and is not a ranking of either stock: sector norms, one-off items and growth stage all affect how a number reads. Not investment advice.

Full JNJ data →  ·  Full PFE data →  ·  Screen 4,900+ stocks →

More Comparisons

All 60 stock comparisons →